A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Published:2019-05 Issue:1 Volume:5 Page:12-21
ISSN:2475-3246
Container-title:Journal of Pancreatic Cancer
language:en
Short-container-title:Journal of Pancreatic Cancer

Author:

Tesfaye Anteneh A.¹,Wang Hongkun²,Hartley Marion L.²,He Aiwu Ruth²,Weiner Louis²,Gabelia Nina²,Kapanadze Lana²,Shezad Muhammad²,Brody Jonathan R.³,Marshall John L.²,Pishvaian Michael J.²

Affiliation:

1. Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

2. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.

3. Department of Surgery, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/pancan.2019.0003

Reference48 articles.

1. Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

3. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

4. Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

5. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Chemotherapy Is Not Guided by Pathologic Treatment Effect After Neoadjuvant Chemotherapy in Pancreatic Cancer;Pancreas;2021-09

2. Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment;Technology in Cancer Research & Treatment;2020-01-01